[HTML][HTML] Biomedical applications of non-small cell lung cancer spheroids

JM Rozenberg, GI Filkov, AV Trofimenko… - Frontiers in …, 2021 - frontiersin.org
Lung malignancies accounted for 11% of cancers worldwide in 2020 and remained the
leading cause of cancer deaths. About 80% of lung cancers belong to non-small cell lung …

Biomedical Applications of Non-Small Cell Lung Cancer Spheroids

JM Rozenberg, GI Filkov… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Lung malignancies accounted for 11% of cancers worldwide in 2020 and remained the
leading cause of cancer deaths. About 80% of lung cancers belong to non-small cell lung …

[HTML][HTML] Biomedical Applications of Non-Small Cell Lung Cancer Spheroids

JM Rozenberg, GI Filkov, AV Trofimenko… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Lung malignancies accounted for 11% of cancers worldwide in 2020 and remained the
leading cause of cancer deaths. About 80% of lung cancers belong to non-small cell lung …

Biomedical Applications of Non-Small Cell Lung Cancer Spheroids.

JM Rozenberg, GI Filkov, AV Trofimenko… - Frontiers in …, 2021 - europepmc.org
Lung malignancies accounted for 11% of cancers worldwide in 2020 and remained the
leading cause of cancer deaths. About 80% of lung cancers belong to non-small cell lung …

[引用][C] Biomedical Applications of Non-Small Cell Lung Cancer Spheroids

JM Rozenberg, GI Filkov, MO Durymanov… - Frontiers in …, 2021 - elibrary.ru

[PDF][PDF] Biomedical Applications of Non-Small Cell Lung Cancer Spheroids. Front

JM Rozenberg, GI Filkov, AV Trofimenko… - Oncol, 2021 - academia.edu
Lung malignancies accounted for 11% of cancers worldwide in 2020 and remained the
leading cause of cancer deaths. About 80% of lung cancers belong to non-small cell lung …

Biomedical Applications of Non-Small Cell Lung Cancer Spheroids

JM Rozenberg, GI Filkov, AV Trofimenko… - Frontiers in …, 2021 - cir.nii.ac.jp
抄録< jats: p> Lung malignancies accounted for 11% of cancers worldwide in 2020 and
remained the leading cause of cancer deaths. About 80% of lung cancers belong to non …